Login to Your Account

Other News To Note

Thursday, June 20, 2013
Amarin Corp. plc, of Dublin, Ireland, said the FDA will convene an advisory committee on Oct. 16 in connection with the agency's review of the supplemental new drug application seeking approval for the use of Vascepa (icosapent ethyl) capsules as an adjunct to diet in the treatment of adult patients with high triglycerides.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription